NovaBay Pharmaceuticals Names David W. Stroman, Ph.D. as Head of Ophthalmic Drug Development
04 oct. 2011 07h00 HE
|
NovaBay Pharmaceuticals, Inc.
Former Alcon Executive With Significant Experience in Ophthalmic Drug Development to Oversee NovaBay's Program for Viral Conjunctivitis (Pink Eye)
EMERYVILLE, Calif., Oct. 4, 2011 (GLOBE NEWSWIRE)...
NovaBay Pharmaceuticals Names Russell A. Hoon as Vice President of Its Advanced Wound Care Business Unit
28 sept. 2011 07h30 HE
|
NovaBay Pharmaceuticals, Inc.
Executive With Three Decades of Experience in Medical Products Industry to Oversee NovaBay's Commercial Launch of NeutroPhase®
EMERYVILLE, Calif., Sept. 28, 2011 (GLOBE NEWSWIRE) --...
NovaBay Pharmaceuticals to Present At the LD MICRO Invitational Conference
21 sept. 2011 13h53 HE
|
NovaBay Pharmaceuticals, Inc.
Management to Present at 1:00 PM PDT / 4:00 PM EDT on September 22, 2011
EMERYVILLE, Calif., Sept. 21, 2011 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage...
NovaBay Pharmaceuticals' Reports Positive Results in Sinus Infection Study
12 sept. 2011 12h39 HE
|
NovaBay Pharmaceuticals, Inc.
Study Results Were Presented at the American Rhinologic Society Meeting on September 10, 2011
EMERYVILLE, Calif., Sept. 12, 2011 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE...
NovaBay Pharmaceuticals Highlighted in Cataract & Refractive Surgery Today
25 août 2011 08h00 HE
|
NovaBay Pharmaceuticals, Inc.
Article Outlines Activity of Aganocide Compounds Against Ophthalmic Pathogens
EMERYVILLE, Calif., Aug. 25, 2011 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSEAmex:NBY), a...
NovaBay Pharmaceuticals to Present at The 2011 Southern California Investor Conference
24 août 2011 16h00 HE
|
NovaBay Pharmaceuticals, Inc.
Webcast to Begin at 10:30 AM PDT, 1:30 PM EDT on August 29, 2011
EMERYVILLE, Calif., Aug. 24, 2011 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage...
NovaBay Pharmaceuticals Reports Second Quarter Financial Results
10 août 2011 08h15 HE
|
NovaBay Pharmaceuticals, Inc.
Three Phase 2 Programs in Dermatology, Urology, and Ophthalmology Advancing
EMERYVILLE, Calif., Aug. 10, 2011 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE Amex:NBY), a...
NovaBay Pharmaceuticals Provides Business Update
11 juil. 2011 07h00 HE
|
NovaBay Pharmaceuticals, Inc.
Reports on Progress in Its Four Business Units and Use of Cash, Including Proceeds From Recent Cash Infusion
EMERYVILLE, Calif., July 11, 2011 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc....
NovaBay Pharmaceuticals Announces the Closing of Its $5.2 Million Registered Direct Offering of Common Stock and Warrants
05 juil. 2011 13h06 HE
|
NovaBay Pharmaceuticals, Inc.
EMERYVILLE, Calif., July 5, 2011 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY) announced today that it has closed its previously announced registered direct offering for the sale...
NovaBay Pharmaceuticals, Inc. Announces Pricing of a $5.2 Million Registered Direct Offering of Common Stock and Warrants
29 juin 2011 09h05 HE
|
NovaBay Pharmaceuticals, Inc.
EMERYVILLE, Calif., June 29, 2011 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE-Amex:NBY) announced that it has entered into definitive subscription agreements with investors, including a...